• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP

CYNATA THERAPEUTICS LIMITED - Announcements

2.70% ! 18.0¢
Market Cap $40.67M  !

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Announcements



Filters [Clear]
  • Price Sensitive: Yes
CYP Block Trade Proceeds to Reduce Director LoansPRICE SENSITIVE16/06/20 download Created with Sketch. 202.1KB
CYP Cynata Successfully Completes Share Purchase PlanPRICE SENSITIVE27/05/20 download Created with Sketch. 174.02KB
CYP Ethics Approval to Commence Clinical Trial in COVID-19PRICE SENSITIVE08/05/20 download Created with Sketch. 210.99KB
CYP Share Purchase Plan BookletPRICE SENSITIVE30/04/20 download Created with Sketch. 169.42KB
CYP Quarterly Activity Report & Appendix 4CPRICE SENSITIVE24/04/20 download Created with Sketch. 293.28KB
CYP Cynata announces $5.55m capital raisingPRICE SENSITIVE22/04/20 download Created with Sketch. 212.56KB
CYP Trading HaltPRICE SENSITIVE20/04/20 download Created with Sketch. 242.54KB
CYP Cynata MSCs beneficial in preclinical ARDS studyPRICE SENSITIVE17/04/20 download Created with Sketch. 241.24KB
CYP Cynata provides guidance on planned clinical trialsPRICE SENSITIVE01/04/20 download Created with Sketch. 195.85KB
CYP Market Update & Additional A$618k R&D Tax RefundPRICE SENSITIVE11/03/20 download Created with Sketch. 201.52KB
CYP Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE20/02/20 download Created with Sketch. 680.83KB
CYP Notice of Allowance from Israel Patent OfficePRICE SENSITIVE06/02/20 download Created with Sketch. 184.85KB
CYP December 2019 Quarterly ReportPRICE SENSITIVE30/01/20 download Created with Sketch. 394.94KB
CYP Cynata Receives UK Regulatory Approval for CLI TrialPRICE SENSITIVE14/01/20 download Created with Sketch. 197.59KB
CYP Cynata Receives $1.892m R&D Tax Incentive RefundPRICE SENSITIVE07/01/20 download Created with Sketch. 159.51KB
CYP Cymerus MSCs Effective in Preclinical Model of SepsisPRICE SENSITIVE05/12/19 download Created with Sketch. 171.52KB
CYP CYP Files Application to Commence Phase 2 CLI Clinical TrialPRICE SENSITIVE25/11/19 download Created with Sketch. 195.33KB
CYP Cynata Awarded Grant for Coronary Artery Disease StudyPRICE SENSITIVE28/10/19 download Created with Sketch. 186.55KB
CYP Notice of Allowance from CIPO for Patent ApplicationPRICE SENSITIVE25/10/19 download Created with Sketch. 185.68KB
CYP September 2019 Quarterly ReportPRICE SENSITIVE24/10/19 download Created with Sketch. 345.42KB
CYP Cynata & Sumitomo Withdraw from Acquisition DiscussionsPRICE SENSITIVE17/10/19 download Created with Sketch. 177.78KB
CYP CYP Advances Towards Osteoarthritis Phase 2 Clinical TrialPRICE SENSITIVE03/10/19 download Created with Sketch. 210.02KB
CYP Cynata Receives US$3 million Fujifilm License FeePRICE SENSITIVE26/09/19 download Created with Sketch. 162.19KB
CYP Fujifilm Exercises License Option in GvHDPRICE SENSITIVE17/09/19 download Created with Sketch. 209.92KB
CYP Trading HaltPRICE SENSITIVE13/09/19 download Created with Sketch. 186.48KB
CYP Appendix 4E & Annual ReportPRICE SENSITIVE23/08/19 download Created with Sketch. 1.26MB
CYP Update on Discussions with Sumitomo and FujifilmPRICE SENSITIVE15/08/19 download Created with Sketch. 182.65KB
CYP Response to ASX Aware QueryPRICE SENSITIVE24/07/19 download Created with Sketch. 785.23KB
CYP Response to ASX Price and Volume QueryPRICE SENSITIVE19/07/19 download Created with Sketch. 537.26KB
CYP Cynata confirms receipt of indicative non-binding proposalPRICE SENSITIVE19/07/19 download Created with Sketch. 184.58KB
CYP Trading HaltPRICE SENSITIVE17/07/19 download Created with Sketch. 214.44KB
CYP June 2019 Quarterly ReportPRICE SENSITIVE04/07/19 download Created with Sketch. 393.87KB
CYP Cynata Strengthens Board & Executive Management TeamPRICE SENSITIVE20/05/19 download Created with Sketch. 205.83KB
CYP March 2019 Quarterly ReportPRICE SENSITIVE26/04/19 download Created with Sketch. 384.45KB
CYP Cynata Extends FUJIFILM Licence Option in GvHDPRICE SENSITIVE21/03/19 download Created with Sketch. 196.96KB
CYP Trading HaltPRICE SENSITIVE19/03/19 download Created with Sketch. 329.31KB
CYP Cynata Receives Favourable Advice on Planned CLI TrialPRICE SENSITIVE12/03/19 download Created with Sketch. 171.99KB
CYP Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE27/02/19 download Created with Sketch. 957.08KB
CYP December 2018 Quarterly ReportPRICE SENSITIVE29/01/19 download Created with Sketch. 350.71KB
CYP CYP Receives Notice of Acceptance from Aust Patent OfficePRICE SENSITIVE07/01/19 download Created with Sketch. 186.08KB
CYP Cynata Completes Clinical Study Report in GvHDPRICE SENSITIVE18/12/18 download Created with Sketch. 181.76KB
CYP NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCsPRICE SENSITIVE13/12/18 download Created with Sketch. 211.91KB
CYP Cynata Receives $1.3m R&D Tax Incentive RefundPRICE SENSITIVE19/11/18 download Created with Sketch. 163.89KB
CYP CYP Receives Notice of Allowance from European Patent OfficePRICE SENSITIVE07/11/18 download Created with Sketch. 185.55KB
CYP September 2018 Quarterly ReportPRICE SENSITIVE23/10/18 download Created with Sketch. 350.92KB
CYP MSCs Demonstrate Anti-Cancer Effects in Pre-Clinical StudiesPRICE SENSITIVE18/10/18 download Created with Sketch. 200.77KB
CYP Cynata MSCs Ameliorate CRS in Preclinical StudyPRICE SENSITIVE19/09/18 download Created with Sketch. 202.31KB
CYP Cynata Advances to Official Meeting with Japanese PMDAPRICE SENSITIVE03/09/18 download Created with Sketch. 170.1KB
CYP Cynata GvHD Trial Meets all Safety & Efficacy EndpointsPRICE SENSITIVE30/08/18 download Created with Sketch. 238.64KB
CYP Appendix 4E & Financial StatementsPRICE SENSITIVE22/08/18 download Created with Sketch. 1.06MB
CYP Cymerus MSCs improve cardiac recovery in preclinical studyPRICE SENSITIVE31/07/18 download Created with Sketch. 203.82KB
CYP June 2018 Quarterly ReportPRICE SENSITIVE11/07/18 download Created with Sketch. 311.1KB
CYP Cynata Enters Development Partnership with RCSIPRICE SENSITIVE02/07/18 download Created with Sketch. 211.31KB
CYP Product Development Program Update & Investor PresentationPRICE SENSITIVE26/06/18 download Created with Sketch. 1.92MB
CYP Positive 28-day Clinical Trial Data in Cohort BPRICE SENSITIVE21/06/18 download Created with Sketch. 215.75KB
CYP Research Collaboration with UNSW for Coronary Artery DiseasePRICE SENSITIVE18/06/18 download Created with Sketch. 170.96KB
CYP Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHDPRICE SENSITIVE12/06/18 download Created with Sketch. 178.42KB
CYP Cynata's MSCs Effective in Model of Diabetic WoundsPRICE SENSITIVE31/05/18 download Created with Sketch. 185.44KB
CYP $5.2m placement of shares to Fidelity InternationalPRICE SENSITIVE30/05/18 download Created with Sketch. 165.54KB
CYP Trading HaltPRICE SENSITIVE28/05/18 download Created with Sketch. 334.93KB
CYP Enrolment Completed in Cynata's Phase 1 Clinical TrialPRICE SENSITIVE24/05/18 download Created with Sketch. 205.81KB
CYP Notice of Allowance from EPO for Patent ApplicationPRICE SENSITIVE07/05/18 download Created with Sketch. 181.73KB
CYP March 2018 Quarterly ReportPRICE SENSITIVE27/04/18 download Created with Sketch. 274.98KB
CYP CYP Completes Patent Application related to CAR-T TherapyPRICE SENSITIVE20/04/18 download Created with Sketch. 169.33KB
CYP Further US Patent Granted for Cynata Cymerus TechnologyPRICE SENSITIVE11/04/18 download Created with Sketch. 162.24KB
CYP FDA Grants Orphan Drug Designation to Cyanta for CYP-001PRICE SENSITIVE28/03/18 download Created with Sketch. 202.82KB
CYP Response to ASX Aware QueryPRICE SENSITIVE28/02/18 download Created with Sketch. 252.89KB
CYP Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE27/02/18 download Created with Sketch. 596.46KB
CYP Excellent Data from Final Preliminary Evaluation PeriodPRICE SENSITIVE27/02/18 download Created with Sketch. 215.85KB
CYP Cynata Engineered MSC Study Review Reveals Promising ResultsPRICE SENSITIVE05/02/18 download Created with Sketch. 190.87KB
CYP December 2017 Quarterly ReportPRICE SENSITIVE30/01/18 download Created with Sketch. 298.09KB
CYP Cynata Treats First Patient in Cohort BPRICE SENSITIVE24/01/18 download Created with Sketch. 207.15KB
CYP Cyanta & Celularity Inc Execute MOUPRICE SENSITIVE23/01/18 download Created with Sketch. 208.01KB
CYP Encouraging Early Data-Cynata Clinical Trial ProceedsPRICE SENSITIVE22/01/18 download Created with Sketch. 213.58KB
CYP Trading HaltPRICE SENSITIVE22/01/18 download Created with Sketch. 194.76KB
CYP Cynata Receives $1.3m R&D Tax Incentive RefundPRICE SENSITIVE14/12/17 download Created with Sketch. 180.45KB
CYP Final Preclinical Asthma Study Confirms EfficacyPRICE SENSITIVE11/12/17 download Created with Sketch. 240.56KB
CYP United States Patent Allowance for Core Cynata TechnologyPRICE SENSITIVE07/12/17 download Created with Sketch. 181.67KB
CYP Enrolment Completed in 1st Cohort of Cynata Clinical TrialPRICE SENSITIVE15/11/17 download Created with Sketch. 202.23KB
CYP September 2017 Quarterly ReportPRICE SENSITIVE27/10/17 download Created with Sketch. 537.32KB
CYP Notice of Annual General Meeting/Proxy FormPRICE SENSITIVE09/10/17 download Created with Sketch. 1.09MB
CYP Cynata to Increase Exposure in JapanPRICE SENSITIVE09/10/17 download Created with Sketch. 208.86KB
CYP US Patent Granted for Cynata Cymerus TechnologyPRICE SENSITIVE27/09/17 download Created with Sketch. 178.12KB
CYP Health Canada Meeting Advances CYP Global Development PlansPRICE SENSITIVE31/08/17 download Created with Sketch. 165.95KB
CYP Appendix 4E & Financial StatementsPRICE SENSITIVE24/08/17 download Created with Sketch. 1005.24KB
CYP Positive Data from CYP MSCs in 2nd Preclinical Asthma StudyPRICE SENSITIVE23/08/17 download Created with Sketch. 226.69KB
CYP June 2017 Quarterly ReportPRICE SENSITIVE28/07/17 download Created with Sketch. 283.27KB
CYP FDA Meeting Provides Clear Path for US Development PlansPRICE SENSITIVE05/07/17 download Created with Sketch. 168.09KB
CYP Cynata Therapeutics GvHD Clinical Trial & Corporate ProgressPRICE SENSITIVE27/06/17 download Created with Sketch. 177.28KB
CYP CYP MSC Data in Asthma Model Published in Sceintific JournalPRICE SENSITIVE22/06/17 download Created with Sketch. 230.33KB
CYP Cynata Files New Patent Application for Cymerus in OncologyPRICE SENSITIVE20/06/17 download Created with Sketch. 186.95KB
CYP United States Patent for Core Cynata TechnologyPRICE SENSITIVE19/06/17 download Created with Sketch. 179.58KB
CYP Treatment Commences in Cynata's World First Clinical TrialPRICE SENSITIVE16/05/17 download Created with Sketch. 209.68KB
CYP Trading HaltPRICE SENSITIVE15/05/17 download Created with Sketch. 191.19KB
CYP March 2017 Quarterly ReportPRICE SENSITIVE26/04/17 download Created with Sketch. 306.13KB
CYP Cynata Advances to Pre-IND Meeting with US FDAPRICE SENSITIVE19/04/17 download Created with Sketch. 168.35KB
CYP CYP Files for New Patent for Oncology ApplicationsPRICE SENSITIVE12/04/17 download Created with Sketch. 163.15KB
CYP CYP in Collaboration on Acute Respiratory Distress SyndromePRICE SENSITIVE11/04/17 download Created with Sketch. 186.84KB
CYP Cynata Partner apceth GmbH & Co Completes Cymerus EvaluationPRICE SENSITIVE31/03/17 download Created with Sketch. 165.81KB
CYP CYP Advances Development of Cymerus for Treatment of AsthmaPRICE SENSITIVE02/03/17 download Created with Sketch. 170.62KB
CYP Block Trade Proceeds to Reduce Director Loans
16/06/20PRICE SENSITIVE download Created with Sketch. 202.1KB
CYP Cynata Successfully Completes Share Purchase Plan
27/05/20PRICE SENSITIVE download Created with Sketch. 174.02KB
CYP Ethics Approval to Commence Clinical Trial in COVID-19
08/05/20PRICE SENSITIVE download Created with Sketch. 210.99KB
CYP Share Purchase Plan Booklet
30/04/20PRICE SENSITIVE download Created with Sketch. 169.42KB
CYP Quarterly Activity Report & Appendix 4C
24/04/20PRICE SENSITIVE download Created with Sketch. 293.28KB
CYP Cynata announces $5.55m capital raising
22/04/20PRICE SENSITIVE download Created with Sketch. 212.56KB
CYP Trading Halt
20/04/20PRICE SENSITIVE download Created with Sketch. 242.54KB
CYP Cynata MSCs beneficial in preclinical ARDS study
17/04/20PRICE SENSITIVE download Created with Sketch. 241.24KB
CYP Cynata provides guidance on planned clinical trials
01/04/20PRICE SENSITIVE download Created with Sketch. 195.85KB
CYP Market Update & Additional A$618k R&D Tax Refund
11/03/20PRICE SENSITIVE download Created with Sketch. 201.52KB
CYP Appendix 4D & Half-Year Financial Statements
20/02/20PRICE SENSITIVE download Created with Sketch. 680.83KB
CYP Notice of Allowance from Israel Patent Office
06/02/20PRICE SENSITIVE download Created with Sketch. 184.85KB
CYP December 2019 Quarterly Report
30/01/20PRICE SENSITIVE download Created with Sketch. 394.94KB
CYP Cynata Receives UK Regulatory Approval for CLI Trial
14/01/20PRICE SENSITIVE download Created with Sketch. 197.59KB
CYP Cynata Receives $1.892m R&D Tax Incentive Refund
07/01/20PRICE SENSITIVE download Created with Sketch. 159.51KB
CYP Cymerus MSCs Effective in Preclinical Model of Sepsis
05/12/19PRICE SENSITIVE download Created with Sketch. 171.52KB
CYP CYP Files Application to Commence Phase 2 CLI Clinical Trial
25/11/19PRICE SENSITIVE download Created with Sketch. 195.33KB
CYP Cynata Awarded Grant for Coronary Artery Disease Study
28/10/19PRICE SENSITIVE download Created with Sketch. 186.55KB
CYP Notice of Allowance from CIPO for Patent Application
25/10/19PRICE SENSITIVE download Created with Sketch. 185.68KB
CYP September 2019 Quarterly Report
24/10/19PRICE SENSITIVE download Created with Sketch. 345.42KB
CYP Cynata & Sumitomo Withdraw from Acquisition Discussions
17/10/19PRICE SENSITIVE download Created with Sketch. 177.78KB
CYP CYP Advances Towards Osteoarthritis Phase 2 Clinical Trial
03/10/19PRICE SENSITIVE download Created with Sketch. 210.02KB
CYP Cynata Receives US$3 million Fujifilm License Fee
26/09/19PRICE SENSITIVE download Created with Sketch. 162.19KB
CYP Fujifilm Exercises License Option in GvHD
17/09/19PRICE SENSITIVE download Created with Sketch. 209.92KB
CYP Trading Halt
13/09/19PRICE SENSITIVE download Created with Sketch. 186.48KB
CYP Appendix 4E & Annual Report
23/08/19PRICE SENSITIVE download Created with Sketch. 1.26MB
CYP Update on Discussions with Sumitomo and Fujifilm
15/08/19PRICE SENSITIVE download Created with Sketch. 182.65KB
CYP Response to ASX Aware Query
24/07/19PRICE SENSITIVE download Created with Sketch. 785.23KB
CYP Response to ASX Price and Volume Query
19/07/19PRICE SENSITIVE download Created with Sketch. 537.26KB
CYP Cynata confirms receipt of indicative non-binding proposal
19/07/19PRICE SENSITIVE download Created with Sketch. 184.58KB
CYP Trading Halt
17/07/19PRICE SENSITIVE download Created with Sketch. 214.44KB
CYP June 2019 Quarterly Report
04/07/19PRICE SENSITIVE download Created with Sketch. 393.87KB
CYP Cynata Strengthens Board & Executive Management Team
20/05/19PRICE SENSITIVE download Created with Sketch. 205.83KB
CYP March 2019 Quarterly Report
26/04/19PRICE SENSITIVE download Created with Sketch. 384.45KB
CYP Cynata Extends FUJIFILM Licence Option in GvHD
21/03/19PRICE SENSITIVE download Created with Sketch. 196.96KB
CYP Trading Halt
19/03/19PRICE SENSITIVE download Created with Sketch. 329.31KB
CYP Cynata Receives Favourable Advice on Planned CLI Trial
12/03/19PRICE SENSITIVE download Created with Sketch. 171.99KB
CYP Appendix 4D & Half-Year Financial Statements
27/02/19PRICE SENSITIVE download Created with Sketch. 957.08KB
CYP December 2018 Quarterly Report
29/01/19PRICE SENSITIVE download Created with Sketch. 350.71KB
CYP CYP Receives Notice of Acceptance from Aust Patent Office
07/01/19PRICE SENSITIVE download Created with Sketch. 186.08KB
CYP Cynata Completes Clinical Study Report in GvHD
18/12/18PRICE SENSITIVE download Created with Sketch. 181.76KB
CYP NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs
13/12/18PRICE SENSITIVE download Created with Sketch. 211.91KB
CYP Cynata Receives $1.3m R&D Tax Incentive Refund
19/11/18PRICE SENSITIVE download Created with Sketch. 163.89KB
CYP CYP Receives Notice of Allowance from European Patent Office
07/11/18PRICE SENSITIVE download Created with Sketch. 185.55KB
CYP September 2018 Quarterly Report
23/10/18PRICE SENSITIVE download Created with Sketch. 350.92KB
CYP MSCs Demonstrate Anti-Cancer Effects in Pre-Clinical Studies
18/10/18PRICE SENSITIVE download Created with Sketch. 200.77KB
CYP Cynata MSCs Ameliorate CRS in Preclinical Study
19/09/18PRICE SENSITIVE download Created with Sketch. 202.31KB
CYP Cynata Advances to Official Meeting with Japanese PMDA
03/09/18PRICE SENSITIVE download Created with Sketch. 170.1KB
CYP Cynata GvHD Trial Meets all Safety & Efficacy Endpoints
30/08/18PRICE SENSITIVE download Created with Sketch. 238.64KB
CYP Appendix 4E & Financial Statements
22/08/18PRICE SENSITIVE download Created with Sketch. 1.06MB
CYP Cymerus MSCs improve cardiac recovery in preclinical study
31/07/18PRICE SENSITIVE download Created with Sketch. 203.82KB
CYP June 2018 Quarterly Report
11/07/18PRICE SENSITIVE download Created with Sketch. 311.1KB
CYP Cynata Enters Development Partnership with RCSI
02/07/18PRICE SENSITIVE download Created with Sketch. 211.31KB
CYP Product Development Program Update & Investor Presentation
26/06/18PRICE SENSITIVE download Created with Sketch. 1.92MB
CYP Positive 28-day Clinical Trial Data in Cohort B
21/06/18PRICE SENSITIVE download Created with Sketch. 215.75KB
CYP Research Collaboration with UNSW for Coronary Artery Disease
18/06/18PRICE SENSITIVE download Created with Sketch. 170.96KB
CYP Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD
12/06/18PRICE SENSITIVE download Created with Sketch. 178.42KB
CYP Cynata's MSCs Effective in Model of Diabetic Wounds
31/05/18PRICE SENSITIVE download Created with Sketch. 185.44KB
CYP $5.2m placement of shares to Fidelity International
30/05/18PRICE SENSITIVE download Created with Sketch. 165.54KB
CYP Trading Halt
28/05/18PRICE SENSITIVE download Created with Sketch. 334.93KB
CYP Enrolment Completed in Cynata's Phase 1 Clinical Trial
24/05/18PRICE SENSITIVE download Created with Sketch. 205.81KB
CYP Notice of Allowance from EPO for Patent Application
07/05/18PRICE SENSITIVE download Created with Sketch. 181.73KB
CYP March 2018 Quarterly Report
27/04/18PRICE SENSITIVE download Created with Sketch. 274.98KB
CYP CYP Completes Patent Application related to CAR-T Therapy
20/04/18PRICE SENSITIVE download Created with Sketch. 169.33KB
CYP Further US Patent Granted for Cynata Cymerus Technology
11/04/18PRICE SENSITIVE download Created with Sketch. 162.24KB
CYP FDA Grants Orphan Drug Designation to Cyanta for CYP-001
28/03/18PRICE SENSITIVE download Created with Sketch. 202.82KB
CYP Response to ASX Aware Query
28/02/18PRICE SENSITIVE download Created with Sketch. 252.89KB
CYP Appendix 4D & Half-Year Financial Statements
27/02/18PRICE SENSITIVE download Created with Sketch. 596.46KB
CYP Excellent Data from Final Preliminary Evaluation Period
27/02/18PRICE SENSITIVE download Created with Sketch. 215.85KB
CYP Cynata Engineered MSC Study Review Reveals Promising Results
05/02/18PRICE SENSITIVE download Created with Sketch. 190.87KB
CYP December 2017 Quarterly Report
30/01/18PRICE SENSITIVE download Created with Sketch. 298.09KB
CYP Cynata Treats First Patient in Cohort B
24/01/18PRICE SENSITIVE download Created with Sketch. 207.15KB
CYP Cyanta & Celularity Inc Execute MOU
23/01/18PRICE SENSITIVE download Created with Sketch. 208.01KB
CYP Encouraging Early Data-Cynata Clinical Trial Proceeds
22/01/18PRICE SENSITIVE download Created with Sketch. 213.58KB
CYP Trading Halt
22/01/18PRICE SENSITIVE download Created with Sketch. 194.76KB
CYP Cynata Receives $1.3m R&D Tax Incentive Refund
14/12/17PRICE SENSITIVE download Created with Sketch. 180.45KB
CYP Final Preclinical Asthma Study Confirms Efficacy
11/12/17PRICE SENSITIVE download Created with Sketch. 240.56KB
CYP United States Patent Allowance for Core Cynata Technology
07/12/17PRICE SENSITIVE download Created with Sketch. 181.67KB
CYP Enrolment Completed in 1st Cohort of Cynata Clinical Trial
15/11/17PRICE SENSITIVE download Created with Sketch. 202.23KB
CYP September 2017 Quarterly Report
27/10/17PRICE SENSITIVE download Created with Sketch. 537.32KB
CYP Notice of Annual General Meeting/Proxy Form
09/10/17PRICE SENSITIVE download Created with Sketch. 1.09MB
CYP Cynata to Increase Exposure in Japan
09/10/17PRICE SENSITIVE download Created with Sketch. 208.86KB
CYP US Patent Granted for Cynata Cymerus Technology
27/09/17PRICE SENSITIVE download Created with Sketch. 178.12KB
CYP Health Canada Meeting Advances CYP Global Development Plans
31/08/17PRICE SENSITIVE download Created with Sketch. 165.95KB
CYP Appendix 4E & Financial Statements
24/08/17PRICE SENSITIVE download Created with Sketch. 1005.24KB
CYP Positive Data from CYP MSCs in 2nd Preclinical Asthma Study
23/08/17PRICE SENSITIVE download Created with Sketch. 226.69KB
CYP June 2017 Quarterly Report
28/07/17PRICE SENSITIVE download Created with Sketch. 283.27KB
CYP FDA Meeting Provides Clear Path for US Development Plans
05/07/17PRICE SENSITIVE download Created with Sketch. 168.09KB
CYP Cynata Therapeutics GvHD Clinical Trial & Corporate Progress
27/06/17PRICE SENSITIVE download Created with Sketch. 177.28KB
CYP CYP MSC Data in Asthma Model Published in Sceintific Journal
22/06/17PRICE SENSITIVE download Created with Sketch. 230.33KB
CYP Cynata Files New Patent Application for Cymerus in Oncology
20/06/17PRICE SENSITIVE download Created with Sketch. 186.95KB
CYP United States Patent for Core Cynata Technology
19/06/17PRICE SENSITIVE download Created with Sketch. 179.58KB
CYP Treatment Commences in Cynata's World First Clinical Trial
16/05/17PRICE SENSITIVE download Created with Sketch. 209.68KB
CYP Trading Halt
15/05/17PRICE SENSITIVE download Created with Sketch. 191.19KB
CYP March 2017 Quarterly Report
26/04/17PRICE SENSITIVE download Created with Sketch. 306.13KB
CYP Cynata Advances to Pre-IND Meeting with US FDA
19/04/17PRICE SENSITIVE download Created with Sketch. 168.35KB
CYP CYP Files for New Patent for Oncology Applications
12/04/17PRICE SENSITIVE download Created with Sketch. 163.15KB
CYP CYP in Collaboration on Acute Respiratory Distress Syndrome
11/04/17PRICE SENSITIVE download Created with Sketch. 186.84KB
CYP Cynata Partner apceth GmbH & Co Completes Cymerus Evaluation
31/03/17PRICE SENSITIVE download Created with Sketch. 165.81KB
CYP CYP Advances Development of Cymerus for Treatment of Asthma
02/03/17PRICE SENSITIVE download Created with Sketch. 170.62KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
18.0¢
Change
-0.005(2.70%)
Mkt cap ! $40.67M
Open High Low Value Volume
18.0¢ 18.0¢ 17.5¢ $8.327K 46.29K

Buyers (Bids)

No. Vol. Price($)
1 38112 18.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 100808 4
View Market Depth
Last trade - 13.52pm 11/08/2025 (20 minute delay) ?
Last
18.0¢
  Change
-0.005 ( 0.00 %)
Open High Low Volume
17.5¢ 18.0¢ 17.5¢ 64533
Last updated 13.52pm 11/08/2025 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.